Epidemiology

Most common cause of nephrotic syndrome in adults, especially in African American and Hispanic populations


Etiology


Pathophysiology

Focal segmental glomerulosclerosis: sclerosis of glomeruli → damage and loss of podocytes


Clinical features


Diagnostics

  • LM: segmental sclerosis and hyalinosisL9210.png
  • EM: effacement of podocyte foot processes (similar to minimal change disease)

Treatment

  • Initial management: supportive therapy including an RAAS inhibitor (i.e., ACEI or ARB).
  • Consider immunosuppressive therapy for all patients with nephrotic syndrome due to FSGS.
    • Prednisone